CND Life Sciences

Scottsdale, AZ · Founded 2017 · Privately Held (backing)

Developer of a medical diagnostic platform designed to detect key pathological markers in the peripheral nervous system. CND Life Sciences is based in Scottsdale, AZ and was founded in 2017. Its last reported valuation was $30.5 million in Mar 2023. It has raised $29.3 million across 7 recorded rounds; the latest was a $4.3 million debt round in Jun 2026.

Last reported valuation
$30.5M
Oct 2026
Priced at
—
Total raised
$29.3M
Last round
Debt
Jun 2026

Who backs CND Life Sciences?

14 investors
InvestorType
Labcorp Venture FundVenture capital
MBX CapitalVenture capital
Cambrian CapitalHedge fund
Blue Stone Venture—
BlueStone Venture Partners—
Cambrian Growth Partners—
HonorHealth—
Laboratory Corporation of America—
Michael J. Fox Foundation—
National Institutes of Neurological Disorders and Stroke—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

CND Life Sciences investors

14 investors are on record for CND Life Sciences, including Labcorp Venture Fund, MBX Capital, Cambrian Capital and Blue Stone Venture. The debt round in Jun 2026 drew 1 investor.

Free account
More of CND Life Sciences with a free account
  • ·The complete investor list: 14 names
  • ·Watch CND Life Sciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like CND Life Sciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View